Current:Home > FinanceFDA expected to authorize new omicron-specific COVID boosters this week-Angel Dreamer Wealth Society D1 Reviews & Insights
FDA expected to authorize new omicron-specific COVID boosters this week
View Date:2024-12-23 19:17:28
The U.S. Food and Drug Administration this week is expected to authorize the first updated versions of the COVID-19 boosters since the pandemic began.
The new shots are reformulated versions of the Moderna and Pfizer-BioNTech vaccines. They're known as "bivalent" vaccines because they are designed to protect against the original strain and the highly contagious omicron variant.
Specifically, the vaccines are programmed to target the BA.4 and BA.5 omicron subvariants, which are the dominant strains infecting people and the most adept at sneaking around the immune system.
The hope is the shots will bolster peoples' waning immunity and provide stronger protection against catching the virus, spreading it and getting sick with COVID and long COVID.
The Biden administration is planning to start making the new shots available after Labor Day to help blunt the impact of what could be yet another surge of infections this fall and winter.
"This is a really important moment in this pandemic," Dr. Ashish Jha, the White House COVID-19 Response Coordinator told NPR. "This is the first major upgrade of the vaccines — first major change in the vaccines — in the last two and a half years."
But the formulation of the boosters and the process for authorizing them has sparked debate among scientists.
For the first time, the FDA is judging how well the vaccines work without results from tests done directly in people. To save time, the FDA is initially evaluating the vaccines with tests in mice along with the results of tests that were done on people of an earlier version of a bivalent vaccine.
Some experts worry that mouse studies aren't very reliable at predicting how well vaccines work in people.
"It could be problematic if the public thinks that the new bivalent boosters are a super-strong shield against infection, and hence increased their behavioral risk and exposed themselves to more virus," says John Moore, an immunologist at Weill Cornell Medicine.
But federal officials defend the decision.
The mouse studies suggest the new vaccines may be about 20 times more protective against omicron than the original shots, and about five times more protective than the first attempt to create omicron-specific bivalent vaccines, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, told NPR in an interview.
"That makes us feel confident that they will do what they are intended to do, which is to produce a good immune response against the BA.4/5 variant, as well as refresh our overall response given the original component of the vaccine as well," Marks says.
The decision to rely on mouse studies became necessary after the FDA in June rejected new boosters that targeted the original strain of omicron, known as BA.1, and instead asked the vaccine companies to develop new shots targeting the strains that had replaced it.
Some scientists think there's the possibility that the new shots could also give people immunity that lasts longer than the original shots, and maybe even protect against new variants that emerge. But more research is needed to confirm that.
Some experts say the data from the BA.1 boosters indicate any potential improvement could be pretty modest at best.
"We want a silver bullet. And the booster has become the silver bullet. And we're putting all our eggs in the vaccine basket," says Dr. Celine Gounder, a senior fellow at the Kaiser Family Foundation. "I am very skeptical as to how much of an improvement these vaccines will yield in terms of population immunity and prevention of severe disease."
Gounder also worries that the country has given up on doing anything else to protect people, like wearing masks and improving ventilation.
But others are more optimistic about the new boosters.
"I personally am very excited about the bivalent vaccines," says Jenna Guthmiller, an assistant professor of immunology at the University of Colorado.
"We really need an updated vaccine to provide protection against the current omicron lineage viruses as well as potentially any future omicron variants," Guthmiller says. "I think it's going to be good."
After the FDA authorizes the vaccines, advisers to the Centers for Disease Control and Prevention will meet Thursday and Friday to decide whether to recommend it and who should receive it. CDC Director Dr. Rochelle Walensky will then have to sign off on that recommendation.
Some experts says only people who are at high risk because of their age or underlying health problems need to get another booster since the first shots are still protecting most people against severe disease. Others say everyone age 12 and older who hasn't been infected or boosted recently should get a new shot.
"I would say that anyone who is longer than six months since their previous boost or previous infection should go get a boost," says E. John Wherry, an immunologist at the University of Pennsylvania.
"Any opportunity to get more boosters into the population to increase vaccine uptake is going to be a positive thing in helping us get through this pandemic," Wherry says.
The Biden administration has purchased more than 170 million doses of the the new boosters, which should start to become available after Labor Day.
It remains unclear how much of a demand there will be for the new boosters, given that many eligible people still haven't gotten their first or second boosters.
veryGood! (85843)
Related
- Too Hot to Handle’s Francesca Farago Gives Birth, Welcomes Twins With Jesse Sullivan
- EA Sports announces over 10,000 athletes have accepted NIL deal for its college football video game
- Driver accused of killing bride in golf cart crash on wedding day is now free on bond
- Photos show humpback whale washed up on Virginia Beach: Officials to examine cause of death
- Why Suits' Gabriel Macht Needed Time Away From Harvey Specter After Finale
- Missing Houston girl E'minie Hughes found safe, man arrested in connection to disappearance
- Travis Kelce Breaks Down in Tears Watching Brother Jason Kelce's Retirement Announcement
- 2024 NFL mock draft: Six QBs land in top 16 picks of post-combine shake-up
- Sister Wives’ Meri Brown Shares Hysterical Farmers Only Dating Profile Video After Kody Split
- Brothers Travis and Jason Kelce honored with bobblehead giveaway at Cavs-Celtics game
Ranking
- Kate Spade Outlet’s Early Black Friday Sale – Get a $259 Bag for $59 & More Epic Deals Starting at $25
- Jack Teixeira pleads guilty to leaking hundreds of highly classified Pentagon documents
- Jason Kelce Tearfully Announces His Retirement From NFL After 13 Seasons
- Lisa Vanderpump Has the Perfect Response to Raquel Leviss' Podcast Shade
- Tua Tagovailoa tackle: Dolphins QB laughs off taking knee to head vs. Rams on 'MNF'
- Authorities say man who killed 2 in small Minnesota town didn’t know his victims
- Horoscopes Today, March 3, 2024
- Falls off US-Mexico border wall in San Diego injure 11 in one day, 10 are hospitalized
Recommendation
-
Mother of Man Found Dead in Tanning Bed at Planet Fitness Gym Details His Final Moments
-
Macy's receives a higher buyout offer of $6.6 billion after rejecting investors' earlier bid
-
They all won an Academy Award for best actress. But who is really best? Our ranking
-
Girl Scouts were told to stop bracelet-making fundraiser for kids in Gaza. Now they can’t keep up
-
Deion Sanders addresses trash thrown at team during Colorado's big win at Texas Tech
-
Just How Much Money Do CO2 Pipeline Companies Stand to Make From the Inflation Reduction Act?
-
How does Selection Sunday work? What to know about how March Madness fields are selected
-
Powerball winning numbers for March 2 drawing: Jackpot rises to over $440 million